Drawing on practical experience, the authors examine key questions and answers about various aspects relating to the enhanced approach for analytical procedure lifecycle management.
Kieran McLaughlin
Advertisement
Kieran McLaughlin is principal scientist at MSD.
Articles by Kieran McLaughlin
Three hypothetical analytical target profiles (ATPs) are provided, reflecting the current thinking of the the European Federation of Pharmaceutical Industries and Associations Analytical Lifecycle Management Team.
Advertisement
Latest Updated Articles
Analytical Procedure Lifecycle Management: Current Status and OpportunitiesPublished: December 2nd 2018 | Updated:
Three Examples of Hypothetical ATPsPublished: December 2nd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
5
